APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Biologics Process Development Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Biologics Process Development Service Market Analysis and Forecast 2026-2032

21 December 2025204 pages

Choose your research edition.

Industry ResearchBiologics Process Development Service Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologics Process Development Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Biologics Process Development Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologics Process Development Service Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologics Process Development Service Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Biologics Process Development Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Biologics Process Development Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biologics Process Development Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biologics Process Development Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biologics Process Development Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Biologics Process Development Service include AGC Biologics, Bora Biologics, Canton Biologics, Catalent Biologics, Evotec, HIPRA, Kemwell Pharma, Lonza and Mabion, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Biologics Process Development Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biologics Process Development Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Biologics Process Development Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biologics Process Development Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biologics Process Development Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biologics Process Development Service revenue, projected growth trends, production technology, application and end-user industry.

Biologics Process Development Service Segment by Company

AGC Biologics

Bora Biologics

Canton Biologics

Catalent Biologics

Evotec

HIPRA

Kemwell Pharma

Lonza

Mabion

NorthX Biologics

Pace Analytical

Rodon Biologics

Samsung Biologics

Sartorius

Thermo Fisher Scientific

WuXi Biologics

Biologics Process Development Service Segment by Type

R&D Scale (1-3L)

Pilot and Scale-Up (50-500L)

Clinical and Commercial Production Scale (1000L and Above)

Biologics Process Development Service Segment by Application

Contract Development and Manufacturing Organization (CDMO)

Professional Technical Service Provider

Large Pharmaceutical Company

Research Institute

Biologics Process Development Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologics Process Development Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologics Process Development Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologics Process Development Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biologics Process Development Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biologics Process Development Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologics Process Development Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biologics Process Development Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. R&D Scale (1-3L) Major Player Table 3. Pilot and Scale-Up (50-500L) Major Player Table 4. Clinical and Commercial Production Scale (1000L and Above) Major Player Table 5. Global Biologics Process Development Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Contract Development and Manufacturing Organization (CDMO) Major Player Table 7. Professional Technical Service Provider Major Player Table 8. Large Pharmaceutical Company Major Player Table 9. Research Institute Major Player Table 10. Biologics Process Development Service Industry Trends Table 11. Biologics Process Development Service Industry Drivers Table 12. Biologics Process Development Service Industry Opportunities and Challenges Table 13. Biologics Process Development Service Industry Restraints Table 14. Global Biologics Process Development Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Biologics Process Development Service Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Biologics Process Development Service Market Share by Region (2021-2026) Table 17. Global Biologics Process Development Service Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Biologics Process Development Service Market Share by Region (2027-2032) Table 19. Global Biologics Process Development Service Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Biologics Process Development Service Revenue Market Share by Players (2021-2026) Table 21. Global Biologics Process Development Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Biologics Process Development Service Key Players Headquarters & Area Served Table 23. Global Biologics Process Development Service Players, Product Type & Application Table 24. Global Biologics Process Development Service Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Biologics Process Development Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Biologics Process Development Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Biologics Process Development Service Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Biologics Process Development Service Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Biologics Process Development Service Revenue Market Share by Type (2021-2026) Table 31. Global Biologics Process Development Service Revenue Market Share by Type (2027-2032) Table 32. Global Biologics Process Development Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Biologics Process Development Service Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Biologics Process Development Service Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Biologics Process Development Service Revenue Market Share by Application (2021-2026) Table 36. Global Biologics Process Development Service Revenue Market Share by Application (2027-2032) Table 37. AGC Biologics Company Information Table 38. AGC Biologics Business Overview Table 39. AGC Biologics Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. AGC Biologics Biologics Process Development Service Product Portfolio Table 41. AGC Biologics Recent Development Table 42. Bora Biologics Company Information Table 43. Bora Biologics Business Overview Table 44. Bora Biologics Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Bora Biologics Biologics Process Development Service Product Portfolio Table 46. Bora Biologics Recent Development Table 47. Canton Biologics Company Information Table 48. Canton Biologics Business Overview Table 49. Canton Biologics Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Canton Biologics Biologics Process Development Service Product Portfolio Table 51. Canton Biologics Recent Development Table 52. Catalent Biologics Company Information Table 53. Catalent Biologics Business Overview Table 54. Catalent Biologics Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Catalent Biologics Biologics Process Development Service Product Portfolio Table 56. Catalent Biologics Recent Development Table 57. Evotec Company Information Table 58. Evotec Business Overview Table 59. Evotec Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Evotec Biologics Process Development Service Product Portfolio Table 61. Evotec Recent Development Table 62. HIPRA Company Information Table 63. HIPRA Business Overview Table 64. HIPRA Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. HIPRA Biologics Process Development Service Product Portfolio Table 66. HIPRA Recent Development Table 67. Kemwell Pharma Company Information Table 68. Kemwell Pharma Business Overview Table 69. Kemwell Pharma Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Kemwell Pharma Biologics Process Development Service Product Portfolio Table 71. Kemwell Pharma Recent Development Table 72. Lonza Company Information Table 73. Lonza Business Overview Table 74. Lonza Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Lonza Biologics Process Development Service Product Portfolio Table 76. Lonza Recent Development Table 77. Mabion Company Information Table 78. Mabion Business Overview Table 79. Mabion Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Mabion Biologics Process Development Service Product Portfolio Table 81. Mabion Recent Development Table 82. NorthX Biologics Company Information Table 83. NorthX Biologics Business Overview Table 84. NorthX Biologics Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. NorthX Biologics Biologics Process Development Service Product Portfolio Table 86. NorthX Biologics Recent Development Table 87. Pace Analytical Company Information Table 88. Pace Analytical Business Overview Table 89. Pace Analytical Biologics Process Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Pace Analytical Biologics Process Development Service Product Portfolio Table 91. Pace Analytical Recent Development Table 92. Rodon Biologics Company Information Table 93. Rodon Biologics Business Overview Table 94. Rodon Biologics Biologics Process Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Rodon Biologics Biologics Process Development Service Product Portfolio Table 96. Rodon Biologics Recent Development Table 97. Samsung Biologics Company Information Table 98. Samsung Biologics Business Overview Table 99. Samsung Biologics Biologics Process Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Samsung Biologics Biologics Process Development Service Product Portfolio Table 101. Samsung Biologics Recent Development Table 102. Sartorius Company Information Table 103. Sartorius Business Overview Table 104. Sartorius Biologics Process Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Sartorius Biologics Process Development Service Product Portfolio Table 106. Sartorius Recent Development Table 107. Thermo Fisher Scientific Company Information Table 108. Thermo Fisher Scientific Business Overview Table 109. Thermo Fisher Scientific Biologics Process Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Thermo Fisher Scientific Biologics Process Development Service Product Portfolio Table 111. Thermo Fisher Scientific Recent Development Table 112. WuXi Biologics Company Information Table 113. WuXi Biologics Business Overview Table 114. WuXi Biologics Biologics Process Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. WuXi Biologics Biologics Process Development Service Product Portfolio Table 116. WuXi Biologics Recent Development Table 117. North America Biologics Process Development Service Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Biologics Process Development Service Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Biologics Process Development Service Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Biologics Process Development Service Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Biologics Process Development Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Biologics Process Development Service Revenue by Country (2021-2026) & (US$ Million) Table 123. North America Biologics Process Development Service Revenue by Country (US$ Million) & (2027-2032) Table 124. Europe Biologics Process Development Service Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Biologics Process Development Service Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Biologics Process Development Service Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Biologics Process Development Service Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Biologics Process Development Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Biologics Process Development Service Revenue by Country (2021-2026) & (US$ Million) Table 130. Europe Biologics Process Development Service Revenue by Country (US$ Million) & (2027-2032) Table 131. China Biologics Process Development Service Revenue by Type (2021-2026) & (US$ Million) Table 132. China Biologics Process Development Service Revenue by Type (2027-2032) & (US$ Million) Table 133. China Biologics Process Development Service Revenue by Application (2021-2026) & (US$ Million) Table 134. China Biologics Process Development Service Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia Biologics Process Development Service Revenue by Type (2021-2026) & (US$ Million) Table 136. Asia Biologics Process Development Service Revenue by Type (2027-2032) & (US$ Million) Table 137. Asia Biologics Process Development Service Revenue by Application (2021-2026) & (US$ Million) Table 138. Asia Biologics Process Development Service Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Biologics Process Development Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Asia Biologics Process Development Service Revenue by Region (US$ Million) & (2021-2026) Table 141. Asia Biologics Process Development Service Revenue by Region (US$ Million) & (2027-2032) Table 142. SAMEA Biologics Process Development Service Revenue by Type (2021-2026) & (US$ Million) Table 143. SAMEA Biologics Process Development Service Revenue by Type (2027-2032) & (US$ Million) Table 144. SAMEA Biologics Process Development Service Revenue by Application (2021-2026) & (US$ Million) Table 145. SAMEA Biologics Process Development Service Revenue by Application (2027-2032) & (US$ Million) Table 146. SAMEA Biologics Process Development Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. SAMEA Biologics Process Development Service Revenue by Country (2021-2026) & (US$ Million) Table 148. SAMEA Biologics Process Development Service Revenue by Country (US$ Million) & (2027-2032) Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Biologics Process Development Service Image Figure 2. Global Biologics Process Development Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biologics Process Development Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. R&D Scale (1-3L) Image Figure 5. Pilot and Scale-Up (50-500L) Image Figure 6. Clinical and Commercial Production Scale (1000L and Above) Image Figure 7. Global Biologics Process Development Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Biologics Process Development Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Contract Development and Manufacturing Organization (CDMO) Image Figure 10. Professional Technical Service Provider Image Figure 11. Large Pharmaceutical Company Image Figure 12. Research Institute Image Figure 13. Global Biologics Process Development Service Market Size (US$ Million) & (2021-2032) Figure 14. Global Biologics Process Development Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Biologics Process Development Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Biologics Process Development Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Biologics Process Development Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Biologics Process Development Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Biologics Process Development Service Revenue Market Share by Type (2021-2032) Figure 21. Global Biologics Process Development Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Biologics Process Development Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Biologics Process Development Service Revenue Market Share by Application (2021-2032) Figure 24. North America Biologics Process Development Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Biologics Process Development Service Revenue Share by Type (2021-2032) Figure 26. North America Biologics Process Development Service Revenue Share by Application (2021-2032) Figure 27. North America Biologics Process Development Service Revenue Share by Country (2021-2032) Figure 28. United States Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Biologics Process Development Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Biologics Process Development Service Revenue Share by Type (2021-2032) Figure 33. Europe Biologics Process Development Service Revenue Share by Application (2021-2032) Figure 34. Europe Biologics Process Development Service Revenue Share by Country (2021-2032) Figure 35. Germany Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Biologics Process Development Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Biologics Process Development Service Revenue Share by Type (2021-2032) Figure 45. China Biologics Process Development Service Revenue Share by Application (2021-2032) Figure 46. Asia Biologics Process Development Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Biologics Process Development Service Revenue Share by Type (2021-2032) Figure 48. Asia Biologics Process Development Service Revenue Share by Application (2021-2032) Figure 49. Asia Biologics Process Development Service Revenue Share by Region (2021-2032) Figure 50. Japan Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Biologics Process Development Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Biologics Process Development Service Revenue Share by Type (2021-2032) Figure 58. SAMEA Biologics Process Development Service Revenue Share by Application (2021-2032) Figure 59. SAMEA Biologics Process Development Service Revenue Share by Country (2021-2032) Figure 60. Brazil Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Biologics Process Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • R&D Scale (1-3L)
  • Pilot and Scale-Up (50-500L)
  • Clinical and Commercial Production Scale (1000L and Above)
Applications
  • Contract Development and Manufacturing Organization (CDMO)
  • Professional Technical Service Provider
  • Large Pharmaceutical Company
  • Research Institute
Companies covered
  • AGC Biologics
  • Bora Biologics
  • Canton Biologics
  • Catalent Biologics
  • Evotec
  • HIPRA
  • Kemwell Pharma
  • Lonza
  • Mabion
  • NorthX Biologics
  • Pace Analytical
  • Rodon Biologics
  • Samsung Biologics
  • Sartorius
  • Thermo Fisher Scientific
  • WuXi Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biologics Process Development Service Market by Type
  3. 1.2.1 Global Biologics Process Development Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 R&D Scale (1-3L)
  5. 1.2.3 Pilot and Scale-Up (50-500L)
  6. 1.2.4 Clinical and Commercial Production Scale (1000L and Above)
  7. 1.3 Biologics Process Development Service Market by Application
  8. 1.3.1 Global Biologics Process Development Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Contract Development and Manufacturing Organization (CDMO)
  10. 1.3.3 Professional Technical Service Provider
  11. 1.3.4 Large Pharmaceutical Company
  12. 1.3.5 Research Institute
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Biologics Process Development Service Market Dynamics
  1. 2.1 Biologics Process Development Service Industry Trends
  2. 2.2 Biologics Process Development Service Industry Drivers
  3. 2.3 Biologics Process Development Service Industry Opportunities and Challenges
  4. 2.4 Biologics Process Development Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biologics Process Development Service Market Perspective (2021-2032)
  2. 3.2 Global Biologics Process Development Service Growth Trends by Region
  3. 3.2.1 Global Biologics Process Development Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biologics Process Development Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Biologics Process Development Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biologics Process Development Service Revenue by Players
  2. 4.1.1 Global Biologics Process Development Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Biologics Process Development Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biologics Process Development Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biologics Process Development Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biologics Process Development Service Key Players Headquarters & Area Served
  7. 4.4 Global Biologics Process Development Service Players, Product Type & Application
  8. 4.5 Global Biologics Process Development Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biologics Process Development Service Market CR5 and HHI
  11. 4.6.3 2025 Biologics Process Development Service Tier 1, Tier 2, and Tier 3
5 Biologics Process Development Service Market Size by Type
  1. 5.1 Global Biologics Process Development Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biologics Process Development Service Revenue by Type (2021-2032)
  3. 5.3 Global Biologics Process Development Service Revenue Market Share by Type (2021-2032)
6 Biologics Process Development Service Market Size by Application
  1. 6.1 Global Biologics Process Development Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biologics Process Development Service Revenue by Application (2021-2032)
  3. 6.3 Global Biologics Process Development Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AGC Biologics
  2. 7.1.1 AGC Biologics Company Information
  3. 7.1.2 AGC Biologics Business Overview
  4. 7.1.3 AGC Biologics Biologics Process Development Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AGC Biologics Biologics Process Development Service Product Portfolio
  6. 7.1.5 AGC Biologics Recent Developments
  7. 7.2 Bora Biologics
  8. 7.2.1 Bora Biologics Company Information
  9. 7.2.2 Bora Biologics Business Overview
  10. 7.2.3 Bora Biologics Biologics Process Development Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bora Biologics Biologics Process Development Service Product Portfolio
  12. 7.2.5 Bora Biologics Recent Developments
  13. 7.3 Canton Biologics
  14. 7.3.1 Canton Biologics Company Information
  15. 7.3.2 Canton Biologics Business Overview
  16. 7.3.3 Canton Biologics Biologics Process Development Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Canton Biologics Biologics Process Development Service Product Portfolio
  18. 7.3.5 Canton Biologics Recent Developments
  19. 7.4 Catalent Biologics
  20. 7.4.1 Catalent Biologics Company Information
  21. 7.4.2 Catalent Biologics Business Overview
  22. 7.4.3 Catalent Biologics Biologics Process Development Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Catalent Biologics Biologics Process Development Service Product Portfolio
  24. 7.4.5 Catalent Biologics Recent Developments
  25. 7.5 Evotec
  26. 7.5.1 Evotec Company Information
  27. 7.5.2 Evotec Business Overview
  28. 7.5.3 Evotec Biologics Process Development Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Evotec Biologics Process Development Service Product Portfolio
  30. 7.5.5 Evotec Recent Developments
  31. 7.6 HIPRA
  32. 7.6.1 HIPRA Company Information
  33. 7.6.2 HIPRA Business Overview
  34. 7.6.3 HIPRA Biologics Process Development Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 HIPRA Biologics Process Development Service Product Portfolio
  36. 7.6.5 HIPRA Recent Developments
  37. 7.7 Kemwell Pharma
  38. 7.7.1 Kemwell Pharma Company Information
  39. 7.7.2 Kemwell Pharma Business Overview
  40. 7.7.3 Kemwell Pharma Biologics Process Development Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Kemwell Pharma Biologics Process Development Service Product Portfolio
  42. 7.7.5 Kemwell Pharma Recent Developments
  43. 7.8 Lonza
  44. 7.8.1 Lonza Company Information
  45. 7.8.2 Lonza Business Overview
  46. 7.8.3 Lonza Biologics Process Development Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Lonza Biologics Process Development Service Product Portfolio
  48. 7.8.5 Lonza Recent Developments
  49. 7.9 Mabion
  50. 7.9.1 Mabion Company Information
  51. 7.9.2 Mabion Business Overview
  52. 7.9.3 Mabion Biologics Process Development Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Mabion Biologics Process Development Service Product Portfolio
  54. 7.9.5 Mabion Recent Developments
  55. 7.10 NorthX Biologics
  56. 7.10.1 NorthX Biologics Company Information
  57. 7.10.2 NorthX Biologics Business Overview
  58. 7.10.3 NorthX Biologics Biologics Process Development Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 NorthX Biologics Biologics Process Development Service Product Portfolio
  60. 7.10.5 NorthX Biologics Recent Developments
  61. 7.11 Pace Analytical
  62. 7.11.1 Pace Analytical Company Information
  63. 7.11.2 Pace Analytical Business Overview
  64. 7.11.3 Pace Analytical Biologics Process Development Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Pace Analytical Biologics Process Development Service Product Portfolio
  66. 7.11.5 Pace Analytical Recent Developments
  67. 7.12 Rodon Biologics
  68. 7.12.1 Rodon Biologics Company Information
  69. 7.12.2 Rodon Biologics Business Overview
  70. 7.12.3 Rodon Biologics Biologics Process Development Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Rodon Biologics Biologics Process Development Service Product Portfolio
  72. 7.12.5 Rodon Biologics Recent Developments
  73. 7.13 Samsung Biologics
  74. 7.13.1 Samsung Biologics Company Information
  75. 7.13.2 Samsung Biologics Business Overview
  76. 7.13.3 Samsung Biologics Biologics Process Development Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Samsung Biologics Biologics Process Development Service Product Portfolio
  78. 7.13.5 Samsung Biologics Recent Developments
  79. 7.14 Sartorius
  80. 7.14.1 Sartorius Company Information
  81. 7.14.2 Sartorius Business Overview
  82. 7.14.3 Sartorius Biologics Process Development Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Sartorius Biologics Process Development Service Product Portfolio
  84. 7.14.5 Sartorius Recent Developments
  85. 7.15 Thermo Fisher Scientific
  86. 7.15.1 Thermo Fisher Scientific Company Information
  87. 7.15.2 Thermo Fisher Scientific Business Overview
  88. 7.15.3 Thermo Fisher Scientific Biologics Process Development Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Thermo Fisher Scientific Biologics Process Development Service Product Portfolio
  90. 7.15.5 Thermo Fisher Scientific Recent Developments
  91. 7.16 WuXi Biologics
  92. 7.16.1 WuXi Biologics Company Information
  93. 7.16.2 WuXi Biologics Business Overview
  94. 7.16.3 WuXi Biologics Biologics Process Development Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 WuXi Biologics Biologics Process Development Service Product Portfolio
  96. 7.16.5 WuXi Biologics Recent Developments
8 North America
  1. 8.1 North America Biologics Process Development Service Revenue (2021-2032)
  2. 8.2 North America Biologics Process Development Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Biologics Process Development Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Biologics Process Development Service Revenue by Type (2027-2032)
  5. 8.3 North America Biologics Process Development Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Biologics Process Development Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Biologics Process Development Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Biologics Process Development Service Revenue by Application (2027-2032)
  9. 8.5 North America Biologics Process Development Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Biologics Process Development Service Revenue by Country
  11. 8.6.1 North America Biologics Process Development Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biologics Process Development Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Biologics Process Development Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biologics Process Development Service Revenue (2021-2032)
  2. 9.2 Europe Biologics Process Development Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biologics Process Development Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biologics Process Development Service Revenue by Type (2027-2032)
  5. 9.3 Europe Biologics Process Development Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biologics Process Development Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biologics Process Development Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biologics Process Development Service Revenue by Application (2027-2032)
  9. 9.5 Europe Biologics Process Development Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biologics Process Development Service Revenue by Country
  11. 9.6.1 Europe Biologics Process Development Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biologics Process Development Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biologics Process Development Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biologics Process Development Service Revenue (2021-2032)
  2. 10.2 China Biologics Process Development Service Revenue by Type (2021-2032)
  3. 10.2.1 China Biologics Process Development Service Revenue by Type (2021-2026)
  4. 10.2.2 China Biologics Process Development Service Revenue by Type (2027-2032)
  5. 10.3 China Biologics Process Development Service Revenue Share by Type (2021-2032)
  6. 10.4 China Biologics Process Development Service Revenue by Application (2021-2032)
  7. 10.4.1 China Biologics Process Development Service Revenue by Application (2021-2026)
  8. 10.4.2 China Biologics Process Development Service Revenue by Application (2027-2032)
  9. 10.5 China Biologics Process Development Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biologics Process Development Service Revenue (2021-2032)
  2. 11.2 Asia Biologics Process Development Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biologics Process Development Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biologics Process Development Service Revenue by Type (2027-2032)
  5. 11.3 Asia Biologics Process Development Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biologics Process Development Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biologics Process Development Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biologics Process Development Service Revenue by Application (2027-2032)
  9. 11.5 Asia Biologics Process Development Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biologics Process Development Service Revenue by Country
  11. 11.6.1 Asia Biologics Process Development Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biologics Process Development Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biologics Process Development Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biologics Process Development Service Revenue (2021-2032)
  2. 12.2 SAMEA Biologics Process Development Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biologics Process Development Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biologics Process Development Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biologics Process Development Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biologics Process Development Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biologics Process Development Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biologics Process Development Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biologics Process Development Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biologics Process Development Service Revenue by Country
  11. 12.6.1 SAMEA Biologics Process Development Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biologics Process Development Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biologics Process Development Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst